Subject Index

Total Page:16

File Type:pdf, Size:1020Kb

Subject Index 52_1107_1136_SI 16.11.2005 9:35 Uhr Seite 1107 Subject Index A – tape 264, 368, 940 α-adjustment 154 AAS, see atomic absorption spectrophotometry adrenocorticotrophic hormone (ACTH) 21 abietic acid 909, 943 adverse drug reaction 401 abrasion 174, 283 aeroallergen 391 absorption through appendage 169 – atopic eczema 391 α-acaridial 329 – avoidance 391 accident 889 aerospace 726 acebutolol hydrochloride 909 African aceclofenac 909 –ebony783 acetaldehyde 943 – mahagony 783 acetone 118, 666 – red padauk wood 783 acetylacetone 697 Agave acetylsalicylic acid 84, 909 – americana 354 Achillea millefolium (yarrow extract) 909 – tequilana 225 aciclovir 909 age 279 acid 110 agent orange 806 – black 48 (CI 65005) 909 AGEP 404 – dye 689 Agfa TSS 355 – halogenated 259 aggravation 204 –hydrochloric261 agricultural worker 272 –nitric261 agriculture 725 –red AICD, see activation-induced cell death – – 14 (azorubine) 909 airborne – – 118 (CI 26410) 909 – allergic contact dermatitis 218, 228, 315, 467, 477, 484, 598, ––359909 627, 654, 788 – violet 17 (CI 42650) 909 – contact urticaria 753, 758 – yellow – irritant contact dermatitis 625 – – 36 (CI 13065, metanil yellow) 909 aircraft manufacture 560 – – 61 (CI 18968) 909 airway symptom 520 acitretin 341 alachlor 953 acneiform alantolactone 55, 789, 909, 954 – folliculitis 229 alclometasone-17,21-dipropionate 909 –lesion265 alclometasone-17-propionate 58 acrodermatitis enteropathica 241 alcohol, see also ethyl 909 acrovesicular dermatitis 401 aldehyde 110, 607, 886 acrylamide 592, 944 algicide 562 acrylate 266, 276, 586, 655, 754, 891, 938, 944 alginate 662 – urethane 588 alimemazine tartrate, see trimeprazine tartrate acrylic 664 alkali 110, 256, 261 – bone cement 741 – resistance 280 –monomer256 alkaline 71 – resin 584 –soap277 acrylonitrile 592, 953 alkanesulfonate 49 acseine 326 alkyl glucoside 954 actarit 909 allantoin 909 ACTH, see adrenocorticotrophic hormone allergen 367,653, 654 actinic keratose 264 – chemical methods 416 activation-induced cell death (AICD) 28 – concentration 379 active sensitization 382, 940 –control326 acute toxic reaction 805 – elicitation 24 ACW,see allergen-controlled wearing apparel – in metalworking fluid acylglutamate 326 – – abietic acid 572 additive 659, 668 – – biocides 574 adhesive 939 ––cobalt573 –layer636 ––colophonium572 – plaster 5 – – dichromate 573 52_1107_1136_SI 16.11.2005 9:35 Uhr Seite 1108 1108 Subject Index – – diethanolamine (DEA) 572 amaryllidaceae 764 – – diglycolamine 572 ambergris 508 ––formaldehyde573 ambrosia 769 – – fragrances 572 amcinonide 57, 909 – – methyldibromo glutaronitrile (MDBGN) 574 Amerchol® L-101, see lanolin alcohol, paraffinum liquidum – – monoethanolamine (MEA) 572 American Contact Dermatitis Society 905 ––nickel573 amethocaine, see also tetracaine hydrochloride 627, 956 ––p-aminoazobenzene (PAAB) 574 amidoamine 500 – – 2-phenoxyethanol (PE) 574 amikacin sulfate 909 – – TEA 572 aminophylline 958 – – triethanolamine (TEA) 572 amino plastic 607 – in the European standard 416 amino-4-N, N-diethylaniline sulfate (TSS Agfa®) 909 – information 894 amino-4-N-ethyl-N-(methanesulfonaminoethyl)-m-toluidine –removal835 (CD 3) 909 – replacement 835 4-amino-3-nitrophenol 526, 533, 956 allergen-controlled 4-aminoantipyrine, see ampyrone – cosmetic 324 p-aminoazobenzene 909, 957 – wearing apparel (ACW) 324 p-aminobenzoic acid 287, 288 allergic ε-aminocaproic acid 637, 909 – contact conjunctivitis 636, 637 p-aminodiphenylamine (hydrochlorode) 957 – contact dermatitis 121, 204, 337, 445, 624, 626, 805 p-amino-N,N-diethylaniline sulfate 956 ––age131 2-2-aminoethoxyethanol, see diglycolamine ––atopy131 aminoethylethanolamine 957 ––DNCB130 aminoglycoside 628, 909 – – ethnic factors 131 aminophenol 5 – – HLA genes 130 – m-aminophenol 525, 526, 531, 909 – – in children 811 – o-aminophenol 525, 531, 989 ––medication132 – p-aminophenol 525, 526, 531, 909, 958 – – of the feet 703 aminophylline 492, 909 – – regional differences 131 amiodarone 102, 311, 313 – – sex 130 amitriptyline 909 – – sex-related differences 814 amlexanox 909 – – twin studies 130 ammoniated mercury 909 – contact hypersensitivity 31 ammonium – contact stomatitis 239 – bituminosulfonate 909 – patch testing 273, 282 – heptamolybdate 909 – – immunohistochemistry 114 – hexachloroplatinate 909 – – histopathology 108, 112 – hydroxide 279–281, 283, –rhinitis490 – persulfate 228, 531, 909, 959 allergy – tetrachloroplatinate 567, 909 –chromate877 – thioglycolate 909, 960 – contact 878 amorolfine 909 –latex882 amoxicillin 960 – nickel 877 ampholyte 739 –rubber gloves878 ampicillin 909, 960 –typeI 877 ampiroxicam 909 alliaceae 761 amplification 18 allicin 954 amprolium (hydrochloride) 909, 961 alloy 538 ampyrone (4-aminoantipyrine) 909 allyl amylcinnamyl alcohol 961 – glycidyl ether 955 amylcinnamaldehyde 961 – isothiocyanate 955 – α-amylcinnamaldehyde 910 allylisopropylacetylurea, see apronalide amyldimethyl-p-aminobenzoic acid 284 allylpropyldisulfide 955 amylocaine hydrochloride 910 alopecia 261 amyloidosis 323 alprenolol 956 p-tert-amylphenol 261 alstroemeria 331, 332, 762, 763 anacardiaceae 764, 787 alstroemeriaceae 762 anacardic acid 962 alternative test 63 anacardium occidentale 2 althiazide 909 analysis, multifactorial 160 alum tanning 705 anaphylactic reaction 382, 663, 672 aluminium 661, 826, 828, 909 anaphylaxis 401 – allergic contact dermatitis 560 anesthetic 627 – allergy 233 – benzocaine 637 –chloride286 – oxybuprocaine 637 – – hexahydrate 909 – proparacaine 637 – hydroxide 356 – proxymetacaine 637 – irritant 560 – tetracaine 637 – production 560 anethole 910, 962 amalgam 226, 239, 568, 654, 661, 909 angioedema 298, 877 – alloying metals 909 angry back syndrome 278 – non gamma 2 909 aniline 910 52_1107_1136_SI 16.11.2005 9:35 Uhr Seite 1109 Subject Index 1109 animal – salt (sodium arsenate) 963 – dander 202 art 726 – feed 558 Artemisia vulgaris 351 – – additive 743 articaine (hydrochloride) 963 – model 174 artifact 380 – product 256 artificial sandalwood 326 anisyl alcohol 962 artist 272 anogenital ascorbic acid 285 – contact dermatitis 233 ash 550 – dermatitis 303, 636, 637 ashy dermatitis 807 antabuse 481 assembly 726 antazoline 910 asteraceae 752, 761, 769, 824 Anthemis nobilis (Chamomilla romana) 910 asthma 490, 567, 568, 663, 781, 877 anthracene 876 astringent 940 anthraquinone dye 687 atenolol 910 anthrax 887 atomic absorption spectrophotometry (AAS) 413 antibiotic 298, 627, 743 – flameless technique 415 – bacitracin 637 – graphite furnace 415 – cefradine 637 atopic 110, 273, 280, 281 – chloramphenicol 637 – dermatitis 174,204,275,542,886 – gentamicin 637 – – effect modifier 148 – kanamycin 637 – – irritant contact dermatitis 147 – neomycin 637 – eczema 329, 881, 889 – oxytetracycline 637 – skin diathesis 278 – penicillin 637 atopy 275, 277, 278, 284, 455, 544 – polymyxin B 637 – patch test (APT) 391 – sulfathiazole 637 – screening 876 – tobramycin 637 – sensitization 214 anticorrosion paint 549 atranol 60, 511, 964 anti-fouling product 807 atranorin 63, 910 anti-freeze 940 atrophy 283 antigen-presenting cell (APC) 17, 19 atropine sulfate 910 antihistamine 381, 435, 632 attributable risk 137, 144 antihistaminic Australian – N-acyl-aspartyl glutamic acid 637 – blackwood 782 – amlexanox 637 –silky oak782 – chlorpheniramine 637 automation 835 –ketotifen637 automobile mechanic 276 – sodium cromoglycate 637 automotive 726 antimicrobial 276, 627 axilla 233 – formaldehyde liberators 660 axillary – hand cleansing agents 660 – dermatitis 560 – hand creams 660 – exposure test 193 – isothiazolinones 660 Ayan 783 – methyldibromo glutaronitrile 660 azaperone 964 antimony trioxide 963 azathioprine 741, 910, 964 antimycotic 629 azidamfenicol 910 antioxidant 501, 511, 611 azo antiozonant 483 – coupling 322 antiperspirant 222, 560 – dye 110, 359, 530, 688 antipyrine (phenazone) 910 azodicarbonamide 910 antiseptic 740, 741 azodiisobutyrodinitrile 910 antiviral drug 629 azorubine, see acid red – idoxiuridine 637 – β-interferon 637 – trifluridine 637 B ANTU, see 1-naphthalenethiourea APC, see antigen-presenting cell baboon syndrome 235, 296, 297, 543, 816 apiaceae 780 bacitracin 628, 910 apoptosis 30, 121 – zinc 910 appendage 170 baker 272, 276, 727, 937 application of test strip 370 balloon 821 apraclonidine 637 balsam apronalide (allylisopropylacetylurea) (fed) 910 – of Peru, see also Myroxylon pereirae 301, 351, 354, 465, 512, APT, see atopy patch test 635, 662, 814, 816, 820 army boots dermatitis 713 – of Tolu, see Myroxylon toluiferum Arnica montana (arnica extract) 910 Bandrowski’s base 13, 528, 529 aromatic barbary fig 754 – amine 528 barber 272 – hydrocarbon solvent 358 barrier arsanilic acid 910 – cream, see also protective cream 175, 282, 283, 790, 838 arsenic 357, 887, 963 – function 273, 279 52_1107_1136_SI 16.11.2005 9:35 Uhr Seite 1110 1110 Subject Index bartender 272 beta-blocker basal – 1-pentbutol 637 – liquefaction degeneration 325 – befunolol 637 – melanosis 319 – betaxolol 637 basic – carteolol 637 – brown 1, see Bismarck brown R – levobunolol 637 – dye 691 – metipranol 637 –red – metoprolol 637 ––22965 –timolol637 – – 46 910, 965 betamethasone bathing attendant 272 – dipropionate 910 beard 526 – 17-valerate 58, 910 beech tar, see Fagus sylvatica beta-pinene 1074 beeswax 283, 662 betaxolol hydrochloride 910 befunolol 910, 965 Betula alba (birch tar) 910 benomyl 806, 910, 966 BHA, see butylated hydroxyanisole benoxinate, see oxybuprocaine BHT, see butylated hydroxytoluene benzalkonium chloride 268 bifonazole 910 benzaldehyde 910 bioavailability 169, 366 benzalkonium
Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2004/0224012 A1 Suvanprakorn Et Al
    US 2004O224012A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0224012 A1 Suvanprakorn et al. (43) Pub. Date: Nov. 11, 2004 (54) TOPICAL APPLICATION AND METHODS Related U.S. Application Data FOR ADMINISTRATION OF ACTIVE AGENTS USING LIPOSOME MACRO-BEADS (63) Continuation-in-part of application No. 10/264,205, filed on Oct. 3, 2002. (76) Inventors: Pichit Suvanprakorn, Bangkok (TH); (60) Provisional application No. 60/327,643, filed on Oct. Tanusin Ploysangam, Bangkok (TH); 5, 2001. Lerson Tanasugarn, Bangkok (TH); Suwalee Chandrkrachang, Bangkok Publication Classification (TH); Nardo Zaias, Miami Beach, FL (US) (51) Int. CI.7. A61K 9/127; A61K 9/14 (52) U.S. Cl. ............................................ 424/450; 424/489 Correspondence Address: (57) ABSTRACT Eric G. Masamori 6520 Ridgewood Drive A topical application and methods for administration of Castro Valley, CA 94.552 (US) active agents encapsulated within non-permeable macro beads to enable a wider range of delivery vehicles, to provide longer product shelf-life, to allow multiple active (21) Appl. No.: 10/864,149 agents within the composition, to allow the controlled use of the active agents, to provide protected and designable release features and to provide visual inspection for damage (22) Filed: Jun. 9, 2004 and inconsistency. US 2004/0224012 A1 Nov. 11, 2004 TOPCAL APPLICATION AND METHODS FOR 0006 Various limitations on the shelf-life and use of ADMINISTRATION OF ACTIVE AGENTS USING liposome compounds exist due to the relatively fragile LPOSOME MACRO-BEADS nature of liposomes. Major problems encountered during liposome drug Storage in vesicular Suspension are the chemi CROSS REFERENCE TO OTHER cal alterations of the lipoSome compounds, Such as phos APPLICATIONS pholipids, cholesterols, ceramides, leading to potentially toxic degradation of the products, leakage of the drug from 0001) This application claims the benefit of U.S.
    [Show full text]
  • List of Union Reference Dates A
    Active substance name (INN) EU DLP BfArM / BAH DLP yearly PSUR 6-month-PSUR yearly PSUR bis DLP (List of Union PSUR Submission Reference Dates and Frequency (List of Union Frequency of Reference Dates and submission of Periodic Frequency of submission of Safety Update Reports, Periodic Safety Update 30 Nov. 2012) Reports, 30 Nov.
    [Show full text]
  • Premenstrual Syndrome: a Natural Approach to Management
    CNI506 8/99 Vol. 5, No. 6 APPLIED NUTRITIONAL SCIENCE REPORTS Copyright © 1997 Advanced Nutrition Publications, Inc. rev. 1999 Premenstrual Syndrome: A Natural Approach to Management BY JOSEPH L. MAYO, MD, FACOG ABSTRACT: Premenstrual syndrome (PMS) is a disorder that imbalances, nutritional insufficiencies, and psychologic factors. occurs during the luteal phase of the menstrual cycle, producing A nutritional approach to PMS that takes into account the complex a diverse number of physical and emotional changes. The most interactions of all bodily systems that influence hormonal balance common symptoms of PMS include bloating, backache, breast and neuroendocrine function, with an emphasis on the liver, is tenderness, food cravings, fatigue, irritability, and depression. recommended. The nutritional factors that have been studied The timing of the appearance and disappearance of symptoms, include vitamin B6, magnesium, zinc, choline, vitamin E, and rather than the presence of specific symptoms, is of more essential fatty acids, in addition to weight management and importance in the diagnosis of PMS. The direct cause of PMS is stress reduction. Herbal therapies have also proven beneficial in unknown, although there are numerous theories relating to hormonal the management of PMS. PREMENSTRUAL SYNDROME symptoms such as bloating, breast tenderness, and headache (Table 1).3-5 These diverse symptoms may range from mild Cyclic symptoms in women of reproductive age have been to incapacitating. In some women a single symptom, such recognized for thousands of years. First appearing in the medical as depression, may predominate, whereas others may have literature in 1931 and originally termed “premenstrual tension,” several symptoms.1 this condition has been renamed “premenstrual syndrome” (PMS) in an effort to take into account the different clinical Table.
    [Show full text]
  • The Phytochemistry of Cherokee Aromatic Medicinal Plants
    medicines Review The Phytochemistry of Cherokee Aromatic Medicinal Plants William N. Setzer 1,2 1 Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA; [email protected]; Tel.: +1-256-824-6519 2 Aromatic Plant Research Center, 230 N 1200 E, Suite 102, Lehi, UT 84043, USA Received: 25 October 2018; Accepted: 8 November 2018; Published: 12 November 2018 Abstract: Background: Native Americans have had a rich ethnobotanical heritage for treating diseases, ailments, and injuries. Cherokee traditional medicine has provided numerous aromatic and medicinal plants that not only were used by the Cherokee people, but were also adopted for use by European settlers in North America. Methods: The aim of this review was to examine the Cherokee ethnobotanical literature and the published phytochemical investigations on Cherokee medicinal plants and to correlate phytochemical constituents with traditional uses and biological activities. Results: Several Cherokee medicinal plants are still in use today as herbal medicines, including, for example, yarrow (Achillea millefolium), black cohosh (Cimicifuga racemosa), American ginseng (Panax quinquefolius), and blue skullcap (Scutellaria lateriflora). This review presents a summary of the traditional uses, phytochemical constituents, and biological activities of Cherokee aromatic and medicinal plants. Conclusions: The list is not complete, however, as there is still much work needed in phytochemical investigation and pharmacological evaluation of many traditional herbal medicines. Keywords: Cherokee; Native American; traditional herbal medicine; chemical constituents; pharmacology 1. Introduction Natural products have been an important source of medicinal agents throughout history and modern medicine continues to rely on traditional knowledge for treatment of human maladies [1]. Traditional medicines such as Traditional Chinese Medicine [2], Ayurvedic [3], and medicinal plants from Latin America [4] have proven to be rich resources of biologically active compounds and potential new drugs.
    [Show full text]
  • Local Anesthetics
    Local Anesthetics Introduction and History Cocaine is a naturally occurring compound indigenous to the Andes Mountains, West Indies, and Java. It was the first anesthetic to be discovered and is the only naturally occurring local anesthetic; all others are synthetically derived. Cocaine was introduced into Europe in the 1800s following its isolation from coca beans. Sigmund Freud, the noted Austrian psychoanalyst, used cocaine on his patients and became addicted through self-experimentation. In the latter half of the 1800s, interest in the drug became widespread, and many of cocaine's pharmacologic actions and adverse effects were elucidated during this time. In the 1880s, Koller introduced cocaine to the field of ophthalmology, and Hall introduced it to dentistry Overwiev Local anesthetics (LAs) are drugs that block the sensation of pain in the region where they are administered. LAs act by reversibly blocking the sodium channels of nerve fibers, thereby inhibiting the conduction of nerve impulses. Nerve fibers which carry pain sensation have the smallest diameter and are the first to be blocked by LAs. Loss of motor function and sensation of touch and pressure follow, depending on the duration of action and dose of the LA used. LAs can be infiltrated into skin/subcutaneous tissues to achieve local anesthesia or into the epidural/subarachnoid space to achieve regional anesthesia (e.g., spinal anesthesia, epidural anesthesia, etc.). Some LAs (lidocaine, prilocaine, tetracaine) are effective on topical application and are used before minor invasive procedures (venipuncture, bladder catheterization, endoscopy/laryngoscopy). LAs are divided into two groups based on their chemical structure. The amide group (lidocaine, prilocaine, mepivacaine, etc.) is safer and, hence, more commonly used in clinical practice.
    [Show full text]
  • Antiparasitic Effects of Medicinal Plants (Part 1)- a Review
    IOSR Journal Of Pharmacy www.iosrphr.org (e)-ISSN: 2250-3013, (p)-ISSN: 2319-4219 Volume 6, Issue 10 Version. 3 (October 2016), PP. 51-66 Antiparasitic effects of medicinal plants (part 1)- A review Prof Dr Ali Esmail Al-Snafi Department of Pharmacology, College of Medicine, Thi qar University, Nasiriyah, Iraq . Cell: +9647801397994. Email: [email protected] Abstract: Many previous researches showed that many plants exerted antiparasitic, antiprotozoal, molluscicidal and insecticidal. These plants included: Achillea santolina, Ailanthus altissima, Allium cepa, Allium sativum, Ammi majus, Anagyris foetida, Antirrhinum majus, Apium graveolens, Arachis hypogaea, Artemisia campestris, Arundo donax, Asclepias curassavica, Ballota nigra, Bauhinia variegate, Betula alba, Bidens tripartite, Brassica nigra, Bryophyllum calycinum, Caccinia crassifolia, Caesalpinia crista,Calendula officinalis, Calotropis procera, Canna indica, Capparis spinosa, Carum carvi, Cassia occidentalis, Celosia cristata, Chenopodium album, Chorchorus capsularis, Chrysanthemum cinerariaefolium, Cichorium intybus, Citrullus colocynthis, Citrus limetta, Citrus medica, Citrus sinensis, Citrus limonum, Citrus aurantifolia, Citrus reticulate, Citrus vitis, Clerodendron inerme, Clitoria ternatea, Corchorus capsularis, Cordia myxa, Coriandrum sativum, Coronilla scorpioides, Coronilla varia, Crocus sativus, Cupressus sempervirens, Cymbopogon schoenanthus, Cyminum cuminum, Cynodon dactylon, Dalbergia sissoo, Datura metel, Datura stramonium, Dianthus caryophyllum, Digitalis purpurea,
    [Show full text]
  • Local Anesthetics – Substances with Multiple Application in Medicine
    ISSN 2411-958X (Print) European Journal of January-April 2016 ISSN 2411-4138 (Online) Interdisciplinary Studies Volume 2, Issue 1 Local Anesthetics – Substances with Multiple Application in Medicine Rodica SÎRBU Ovidius University of Constanta, Faculty of Pharmacy, Campus Corp B, University Alley No. 1, Constanta, Romania Emin CADAR UMF Carol Davila Bucharest, Faculty of Pharmacy, Str. Traian Vuia No. 6, Sector 2, Bucharest, Romania Cezar Laurențiu TOMESCU Ovidius University of Constanta, Faculty of Medicine, Campus Corp B, University Alley No. 1, Constanta, Romania Cristina-Luiza ERIMIA Corresponding author, [email protected] Ovidius University of Constanta, Faculty of Pharmacy, Campus Corp B, University Alley No. 1, Constanta, Romania Stelian PARIS Ovidius University of Constanta, Faculty of Pharmacy, Campus Corp B, University Alley No. 1, Constanta, Romania Aneta TOMESCU Ovidius University of Constanta, Faculty of Medicine, Campus Corp B, University Alley No. 1, Constanta, Romania Abstract Local anesthetics are substances which, by local action groups on the runners, cause loss of reversible a painful sensation, delimited corresponding to the application. They allow small surgery, short in duration and the endoscopic maneuvers. May be useful in soothe teething pain of short duration and in the locking of the nervous disorders in medical care. Local anesthesia is a process useful for the carrying out of surgery and of endoscopic maneuvers, to soothe teething pain in certain conditions, for depriving the temporary structures peripheral nervous control. Reversible locking of the transmission nociceptive, the set of the vegetative and with a local anesthetic at the level of the innervations peripheral nerve, roots and runners, a trunk nervous, around the components of a ganglion or coolant is cefalorahidian practice anesthesia loco-regional.
    [Show full text]
  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
    MTC eHealth DSI [eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01
    [Show full text]
  • Allium Hookeri Extracts Improve Scopolamine-Induced Cognitive Impairment Via Activation of the Cholinergic System and Anti-Neuroinflammation in Mice
    nutrients Article Allium hookeri Extracts Improve Scopolamine-Induced Cognitive Impairment via Activation of the Cholinergic System and Anti-Neuroinflammation in Mice Ji-Hye Choi 1,2,†, Eun-Byeol Lee 1,† , Hwan-Hee Jang 1 , Youn-Soo Cha 2, Yong-Soon Park 3 and Sung-Hyen Lee 1,* 1 National Institute of Agricultural Sciences, Rural Development Administration, Wanju 55365, Jeonbuk, Korea; [email protected] (J.-H.C.); [email protected] (E.-B.L.); [email protected] (H.-H.J.) 2 Department of Food Science and Human Nutrition, Jeonbuk National University, Jeonju 54896, Jeonbuk, Korea; [email protected] 3 Department of Food and Nutrition, Hanyang University, Seongdong, Seoul 04763, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-63-238-3681; Fax: +82-63-238-3843 † These authors contributed equally to this work. Abstract: Allium hookeri (AH) is a medicinal food that has been used in Southeast Asia for various physiological activities. The objective of this study was to investigate the activation of the cholinergic system and the anti-neuroinflammation effects of AH on scopolamine-induced memory impairment in mice. Scopolamine (1 mg/kg body weight, i.p.) impaired the performance of the mice on the Y-maze test, passive avoidance test, and water maze test. However, the number of error actions was reduced in the AH groups supplemented with leaf and root extracts from AH. AH treatment Citation: Choi, J.-H.; Lee, E.-B.; Jang, improved working memory and avoidance times against electronic shock, increased step-through H.-H.; Cha, Y.-S.; Park, Y.-S.; Lee, S.-H.
    [Show full text]
  • Marrakesh Agreement Establishing the World Trade Organization
    No. 31874 Multilateral Marrakesh Agreement establishing the World Trade Organ ization (with final act, annexes and protocol). Concluded at Marrakesh on 15 April 1994 Authentic texts: English, French and Spanish. Registered by the Director-General of the World Trade Organization, acting on behalf of the Parties, on 1 June 1995. Multilat ral Accord de Marrakech instituant l©Organisation mondiale du commerce (avec acte final, annexes et protocole). Conclu Marrakech le 15 avril 1994 Textes authentiques : anglais, français et espagnol. Enregistré par le Directeur général de l'Organisation mondiale du com merce, agissant au nom des Parties, le 1er juin 1995. Vol. 1867, 1-31874 4_________United Nations — Treaty Series • Nations Unies — Recueil des Traités 1995 Table of contents Table des matières Indice [Volume 1867] FINAL ACT EMBODYING THE RESULTS OF THE URUGUAY ROUND OF MULTILATERAL TRADE NEGOTIATIONS ACTE FINAL REPRENANT LES RESULTATS DES NEGOCIATIONS COMMERCIALES MULTILATERALES DU CYCLE D©URUGUAY ACTA FINAL EN QUE SE INCORPOR N LOS RESULTADOS DE LA RONDA URUGUAY DE NEGOCIACIONES COMERCIALES MULTILATERALES SIGNATURES - SIGNATURES - FIRMAS MINISTERIAL DECISIONS, DECLARATIONS AND UNDERSTANDING DECISIONS, DECLARATIONS ET MEMORANDUM D©ACCORD MINISTERIELS DECISIONES, DECLARACIONES Y ENTEND MIENTO MINISTERIALES MARRAKESH AGREEMENT ESTABLISHING THE WORLD TRADE ORGANIZATION ACCORD DE MARRAKECH INSTITUANT L©ORGANISATION MONDIALE DU COMMERCE ACUERDO DE MARRAKECH POR EL QUE SE ESTABLECE LA ORGANIZACI N MUND1AL DEL COMERCIO ANNEX 1 ANNEXE 1 ANEXO 1 ANNEX
    [Show full text]
  • Vr Meds Ex01 3B 0825S Coding Manual Supplement Page 1
    vr_meds_ex01_3b_0825s Coding Manual Supplement MEDNAME OTHER_CODE ATC_CODE SYSTEM THER_GP PHRM_GP CHEM_GP SODIUM FLUORIDE A12CD01 A01AA01 A A01 A01A A01AA SODIUM MONOFLUOROPHOSPHATE A12CD02 A01AA02 A A01 A01A A01AA HYDROGEN PEROXIDE D08AX01 A01AB02 A A01 A01A A01AB HYDROGEN PEROXIDE S02AA06 A01AB02 A A01 A01A A01AB CHLORHEXIDINE B05CA02 A01AB03 A A01 A01A A01AB CHLORHEXIDINE D08AC02 A01AB03 A A01 A01A A01AB CHLORHEXIDINE D09AA12 A01AB03 A A01 A01A A01AB CHLORHEXIDINE R02AA05 A01AB03 A A01 A01A A01AB CHLORHEXIDINE S01AX09 A01AB03 A A01 A01A A01AB CHLORHEXIDINE S02AA09 A01AB03 A A01 A01A A01AB CHLORHEXIDINE S03AA04 A01AB03 A A01 A01A A01AB AMPHOTERICIN B A07AA07 A01AB04 A A01 A01A A01AB AMPHOTERICIN B G01AA03 A01AB04 A A01 A01A A01AB AMPHOTERICIN B J02AA01 A01AB04 A A01 A01A A01AB POLYNOXYLIN D01AE05 A01AB05 A A01 A01A A01AB OXYQUINOLINE D08AH03 A01AB07 A A01 A01A A01AB OXYQUINOLINE G01AC30 A01AB07 A A01 A01A A01AB OXYQUINOLINE R02AA14 A01AB07 A A01 A01A A01AB NEOMYCIN A07AA01 A01AB08 A A01 A01A A01AB NEOMYCIN B05CA09 A01AB08 A A01 A01A A01AB NEOMYCIN D06AX04 A01AB08 A A01 A01A A01AB NEOMYCIN J01GB05 A01AB08 A A01 A01A A01AB NEOMYCIN R02AB01 A01AB08 A A01 A01A A01AB NEOMYCIN S01AA03 A01AB08 A A01 A01A A01AB NEOMYCIN S02AA07 A01AB08 A A01 A01A A01AB NEOMYCIN S03AA01 A01AB08 A A01 A01A A01AB MICONAZOLE A07AC01 A01AB09 A A01 A01A A01AB MICONAZOLE D01AC02 A01AB09 A A01 A01A A01AB MICONAZOLE G01AF04 A01AB09 A A01 A01A A01AB MICONAZOLE J02AB01 A01AB09 A A01 A01A A01AB MICONAZOLE S02AA13 A01AB09 A A01 A01A A01AB NATAMYCIN A07AA03 A01AB10 A A01
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]